ALDX: Aldeyra Therapeutics, Inc. Stock

by  •  • Comments Off on ALDX: Aldeyra Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 284.05
Enterprise Value ($M) 271.21
Book Value ($M) 85.10
Book Value / Share 1.43
Price / Book 3.34
NCAV ($M) 84.50
NCAV / Share 1.42
Price / NCAV 3.36

Profitability (mra)
Return on Invested Capital (ROIC) -0.44
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.37

Liquidity (mrq)
Quick Ratio 6.80
Current Ratio 6.80

Balance Sheet (mrq) ($M)
Current Assets 116.72
Assets 117.32
Liabilities 32.22
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Perceptive Advisors Llc 15.60 7.94
02-13 13G Vanguard Group Inc 6.68
01-29 13G BlackRock, Inc. 5.80 251.89

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-03-07 10-K Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-14 50,640 282,241 17.94
2025-01-13 76,707 342,681 22.38
2025-01-10 106,616 442,604 24.09

(click for more detail)

Similar Companies
AKAN – Akanda Corp. AKBA – Akebia Therapeutics, Inc.
ALBT – Avalon GloboCare Corp. ALGS – Aligos Therapeutics, Inc.
ALTS – JanOne Inc.


Financial data and stock pages provided by
Fintel.io